Private equity investment in life sciences sector
Exploring some of the potential benefits and challenges for life sciences companies considering PE investment.
by multiple authors
4 of 6 Insights
Taylor Wessing advises Gundlach Automotive Corporation on the sale of online retailer Goodwheel
by multiple authors
Taylor Wessing advises Optimum Group on the acquisition of FlexoPrint Group from Capidea
by multiple authors
Update on France's FDI screening procedure for International Investment
Advising on transformational sale of Inflexion portfolio group, Glide
by James Goold and Suzy Davis
Advising The Rohatyn Group on investment in Optimapharm d.d.
by multiple authors
Taylor Wessing advises UK Government on establishment of new £500m 'Future Fund' to support start-up technology and life sciences companies
by Angus Miln
Advising Glenmark on product portfolio sale
by multiple authors
COVID-19: Private equity investors and investor directors – dealing with distress
